Nasdaq.com (US)
Enlivex Therapeutics Ltd. to Hold Extraordinary General Meeting to Vote on Increasing Authorized Share Capital to NIS 9,120,000,000
Enlivex Therapeutics Ltd. announced that it will hold an Extraordinary General Meeting of Shareholders on Friday, December 4, 2026, beginning at 10:00 a.m. Israel time, at the offices…